HealthAratus
IntelliStreamToolsFor VendorsHow It Works
Sign InGet Started
HEALTHARATUS BETA

See how HealthAratus builds intelligence →

Back
Company

GeneSight

vendor1 tracked tool
imaging_diagnostics category intelligence

Tracked Tools by GeneSight

G
GeneSightHealthAratus Score1.2

GeneSight is a pharmacogenomic test by Myriad Genetics that analyzes a patient's DNA to determine how their genes may affect their response to psychiatric and neurological medications, helping clinicians select more effective antidepressants, antipsychotics, and other psychotropic drugs while avoiding medications likely to cause adverse effects. The test is one of the most widely used pharmacogenomic tools in psychiatry, covering 60+ medications across multiple drug classes.

HealthAratusHealthAratus

Intelligence for healthcare AI after deployment.

HealthAratus

  • How It Works
  • About

For Industry

  • For Users
  • For Vendors
  • For Hospitals & Healthcare Facilities
  • For AI Healthcare Investors

Company

  • Investor Relations
  • Beta Feedback & Support

Legal

  • Privacy Policy
  • Terms of Service
2026 — Powered by AI Health Labs Research

HealthAratus is the institutional standard for medical AI validation in the United States. The MOAT Protocol aggregates ground-truth performance signals from a credentialed network of 60,000 verified U.S. users, delivering real-world evidence that health systems, payers, and procurement leaders use to evaluate AI tools before deployment.

The HealthAratus Score is a composite reputation metric computed from four weighted factors: Evidence, Deployment, User Experience and Innovation. Scores are EWMA-smoothed daily and capped to prevent intra-day volatility.

Beta Feedback